期刊
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
卷 91, 期 -, 页码 -出版社
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bmcl.2023.129351
关键词
IBD; EP4 agonist; Intestinally targeted drug delivery
A property-focused optimization strategy was used to modify a class of EP4 agonists, resulting in a colon-targeted delivery prodrug with minimal exposure in the plasma. Oral administration of the prodrug showed tissue-specific activation of the EP4 receptor and modulation of immune genes in the colon. Further understanding and evaluation of this therapeutic modality is required using this tool molecule in rodent models of human disease.
A property-focused optimization strategy was employed to modify the carboxylic acid head group of a class of EP4 agonists in order to minimize its absorption upon oral administration. The resulting oxalic acid monohydrazide-derived carboxylate isostere demonstrated utility as a class of prodrug showing colon-targeted delivery of parent agonist 2, with minimal exposure observed in the plasma. Oral administration of NXT-10796 demonstrated tissue specific activation of the EP4 receptor through modulation of immune genes in the colon, without modulation of EP4 driven biomarkers in the plasma compartment. Although further in depth understanding of the conversion of NXT-10796 is required for further assessment of the developability of this series of prodrugs, using NXT-10796 as a tool molecule has allowed us to confirm that tissue-specific modulation of an EP4-modulated gene signature is possible, which allows for further evaluation of this therapeutic modality in rodent models of human disease.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据